AbbVie in talks to sell $5 billion women’s drugs portfolio

AbbVie in talks to sell $5 billion women’s drugs portfolio

U.S. drugmaker AbbVie Inc is in discussions to sell a roughly $5 billion portfolio of women’s drugs acquired last year through its $63 billion purchase of Botox maker Allergan Plc, sources familiar with the matter told Reuters. The move revives a process to sell the...
Private equity investors fret over record U.S. buyout prices

Private equity investors fret over record U.S. buyout prices

Private equity firms are paying more for leveraged buyouts to keep pace with soaring valuations of acquisition targets, making some investors leery of whether the industry can keep delivering on promises of lucrative returns. The booming stock market and cheap debt...
PE-backed Software startup Sprinklr confidentially files for IPO

PE-backed Software startup Sprinklr confidentially files for IPO

Sprinklr, which counts Microsoft Corp and telecom operator Verizon Communication Inc as customers, has confidentially filed with the U.S. Securities and Exchange Commission for an initial public offering, the software company said on Monday. The New York-based firm...